The FIA is introducing immediate changes to energy management in Formula 1, but what do they mean in practice? And how will ...

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...

“Elevated IIV has been found to predict progression from normal cognitive status to mild cognitive impairment and dementia, ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Sotatercept significantly reduces pulmonary vascular resistance in patients with CpcPH–HFpEF compared with placebo, according to a trial.

Kyverna Therapeutics reported robust early Phase 2 miv-cel data in gMG, showing 100% response rates and deep, durable ...

The 2026 ASCO Annual Meeting will be held from May 28 to June 2, 2026. The full text of the abstract and poster will be available on June 1, 2026, the day of the presentation.

High intensity interval training boosts exercise capacity in adolescents and young adults with repaired tetralogy of Fallot, without causing harmful changes in heart structure or function.

Although GLP-1 analogs were associated with increased risks for cognitive impairment, they had a larger, protective effect ...

After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs ...

Investigational ADC QLS5132 showed promising clinical benefit and manageable safety in Phase I trial patients with platinum-resistant ovarian cancer.